On this page you will find news concerning Genexpath's presence at trade fairs, conferences and congresses as well as its presence in the press.
Events
Come and meet us at major industry conferences and discover the team and the products.
No event to come
-
EHA 2024
June 13 to 16, 2024
Genexpath will be taking part in the European Hematology Association congress in Madrid at IFEMA Madrid Recinto Ferial from June 13 to 16, 2024. The EHA (European Hematology Association) congress is an annual scientific event bringing together researchers, clinicians and experts from
-
VivaTechnology 2024
May 22 to 24, 2024
Genexpath will be present at Viva Technology from May 22 to 24, 2024 at the Porte de Versailles exhibition center in Paris, stand D53. We'll be there with the We Are Normandy collective and 17 other companies
-
Meet2Win 2024
May 16 and 17, 2024
Genexpath will be present at the Meet2Win convention on May 16 and 17, 2024 at the Cité Mondiale Convention Center in Bordeaux. Meet2Win is an annual conference that brings together players in the pharmaceutical industry
-
SFH at the Palais des Congrès Paris - 2024
27 au 29 Mars 2024
Genexpath will be present at the 44th SFH 2024 congress from March 27 to 29 at the Palais des Congrès de la Porte Maillot. The French Society of Hematology (SFH) is a medical organization bringing together
-
Lysa Days in Tours - 2024
31 Janvier au 2 février 2024
Genexpath was present at the LYSA days on January 31, February 1 and 2, 2024 in Tours. These days provide an opportunity to disseminate information and scientific advances relating to the understanding and treatment of lymphomas. They bring together
-
Carrefour Pathologie 2023, Paris-La-Défense
November 22nd to 24th
Carrefour Pathologie is the annual national congress of pathological anatomy and cytology (ACP) organized by the Société Française de Pathologie (SFP). Carrefour Pathologie offers a dense 3-day program featuring SFP plenary lectures, SFP symposia and three histoseminars,
Media
-
A new start-up is launching in Rouen: Genexpath. Created in November 2020, supported by Henri Becquerel and Normandie Valorisation, it produces and markets diagnostic kits for lymphomas and sarcomas.
-
Created in November 2020, the start-up Genexpath is in the industrialization phase of diagnostic kits for certain cancers. Juliette Renauld, the manager, hopes to be able to market them at the end of the spring. In the premises of the Genexpath start-up, near the
-
Backed by the Henri-Becquerel regional cancer center in Rouen, the young start-up Genexpath born in November 2020 has already designed, manufactured and marketed two diagnostic kits for lymphoma and sarcoma cancers.
-
Genexpath will develop, manufacture and market kits for lymphomas and sarcomas. It was created in Normandy and is based in Rouen. Genexpath was born The Genexpath company